New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities

Drugs - United Kingdom
doi 10.1007/s40265-014-0301-x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Treatment of Venous Thromboembolism With New Oral Anticoagulants

Italian Journal of Medicine
Medicine
2013English

Prevention and Treatment of Venous Thromboembolism With New Oral Anticoagulants: A Practical Update for Clinicians

Thrombosis
Cardiovascular MedicineHematologyCardiology
2013English

Development of Treatment of Cancer-Associated Venous Thromboembolism With Direct Oral Anticoagulants

The Japanese Journal of Phlebology
2020English

Hypoalbuminemia for the Prediction of Venous Thromboembolism and Treatment of Direct Oral Anticoagulants in Metastatic Gastric Cancer Patients

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

Potential Role of New Anticoagulants for Prevention and Treatment of Venous Thromboembolism in Cancer Patients

Vascular Health and Risk Management
2013English

Recent Advances in the Treatment of Venous Thromboembolism in the Era of the Direct Oral Anticoagulants

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Anticoagulants in Venous Thromboembolism.

BMJ
1989English

Pcv138 - Treatment Patterns of Patients With Venous Thromboembolism Treated With Oral Anticoagulants in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy